Catalent to buy GPP-backed Belgian cell therapy firm for $315 mln
Catalent has agreed to acquire MaSTherCell Global, which is backed by Great Point Partners, SFPI-FPIM and Orgenesis Inc, for $315 million in cash.
3 February 2020•6 mins read
Catalent has agreed to acquire MaSTherCell Global, which is backed by Great Point Partners, SFPI-FPIM and Orgenesis Inc, for $315 million in cash.
Paradigm Equity Partners acquires upholstery and performance fabric maker STI Fabrics
14 hours ago · 1 min read
KKR and Hildred merge diagnostics businesses Sapphiros and binx health into Onvaro
14 hours ago · 2 mins read
Eir Partners-backed Porter acquires health plan analytics firm Pareto Intelligence
14 hours ago · 1 min read
Bain Capital’s LeanTaaS snaps up hospital care transition platform Aidin
14 hours ago · 2 mins read
Carlyle-backed Vantive agrees hemodialysis business sale to Rockwell Medical
15 hours ago · 2 mins read
Novacap completes OSI Maritime Systems acquisition as first Fund VII deal
15 hours ago · 2 mins read
Long Arc-backed Robertson Stephens adds Denver adviser Altius Financial
15 hours ago · 1 min read
